Glaucoma: Looking Ahead to Improved Compliance and Visual Outcomes
Including proceedings from a symposium during the American Academy of Ophthalmology's Annual Meeting in Las Vegas, Nevada
Activity Date: April 2007  — Activity Info: Volume 4, (3)
 

Full Disclosure Policy Affecting CME Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

Henry D. Jampel, MD, MHS
Odd Fellows and Rebekahs
Professor of Ophthalmology
Johns Hopkins University School of Medicine
Baltimore, Maryland
• Dr Jampel reports serving as a consultant for Alcon Laboratories; and holding stock in Allergan, Inc.

PARTICIPATING FACULTY

Paul P. Lee, MD, JD
Professor of Ophthalmology
Duke University Eye Center
Durham, North Carolina
• Dr Lee reports receiving grants/research support from Allergan, Inc, Merck & Co, Inc, and Pfizer, Inc; serving as a consultant for and receiving honoraria from Alcon Laboratories, Allergan, Inc, and Pfizer, Inc; and holding stock in Merck & Co, Inc.

Harry A. Quigley, MD
A. Edward Maumenee Professor of Ophthalmology
Director, Glaucoma Service
Director, Dana Center for Preventive Ophthalmology
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
• Dr Quigley reports receiving grants/research support from and serving as a consultant for Alcon Laboratories, Allergan, Inc, Pfizer, Inc, and Zeiss/Meditec.

Gail F. Schwartz, MD
Glaucoma Consultants
Greater Baltimore Medical Center
Assistant Professor
Wilmer Eye Institute
Johns Hopkins University School of Medicine
Baltimore, Maryland
• Dr Schwartz reports receiving grants/ research support from Allergan, Inc, Pfizer, Inc, and Santen; serving as a consultant for Pfizer, Inc; and receiving honoraria from Merck & Co, Inc, Pfizer, Inc, and Santen.

James C. Tsai, MD
Robert R. Young Professor and Chair
Department of Ophthalmology and Visual Science
Yale University School of Medicine
New Haven, Connecticut
• Dr Tsai reports receiving grants/research funding and serving as a consultant for Alcon Laboratories, Allergan, Inc, and Pfizer, Inc; and serving on the speakers' bureau for Alcon Laboratories, Allergan, Inc, Merck & Co, Inc, and Pfizer, Inc.

Notice: No faculty member has indicated that his/her article will reference unlabeled/unapproved uses of drugs or devices.

Johns Hopkins Advanced Studies in Ophthalmology provides disclosure information from contributing authors, lead presenters, and participating faculty. Johns Hopkins Advanced Studies in Ophthalmology does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?